pETM: a penalized Exponential Tilt Model for analysis of correlated high‐dimensional DNA methylation data
暂无分享,去创建一个
Yong Chen | Shuang Wang | Ya Wang | Yun Li | Hokeun Sun | Yun Li | Yong Chen | Hokeun Sun | Shuang Wang | Ya Wang
[1] S. Nomoto,et al. Inverse Correlation between Cyclin A1 Hypermethylation and p53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing , 2004, Cancer Research.
[2] Ronald D. Alvarez,et al. Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer , 2011, Clinical Cancer Research.
[3] A. Børresen-Dale,et al. COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.
[4] N. Joste,et al. Differential Epigenetic Regulation of TOX Subfamily High Mobility Group Box Genes in Lung and Breast Cancers , 2012, PloS one.
[5] P. Arrigo,et al. An integrated genomic and proteomic approach to identify signatures of endosulfan exposure in hepatocellular carcinoma cells. , 2015, Pesticide biochemistry and physiology.
[6] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[7] Gilbert S Omenn,et al. An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer , 2009, Nature Biotechnology.
[8] M. Tatematsu,et al. Chemical genomic screening for methylation‐silenced genes in gastric cancer cell lines using 5‐aza‐2′‐deoxycytidine treatment and oligonucleotide microarray , 2006, Cancer science.
[9] Scott M Langevin,et al. Epigenetics of lung cancer. , 2015, Translational research : the journal of laboratory and clinical medicine.
[10] H. Aburatani,et al. Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers. , 2006, Biochemical and biophysical research communications.
[11] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[12] W. Han,et al. Genome Wide Methylome Alterations in Lung Cancer , 2015, PloS one.
[13] H. Carén,et al. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma , 2012, Molecular Cancer.
[14] A. Corvalán,et al. Identification of novel upregulated microRNAs in the pathogenesis of gastric cancer by the use of open access databases and bioinformatics tools. , 2015 .
[15] Yang Ning,et al. Semiparametric Tests for Identifying Differentially Methylated Loci With Case–Control Designs Using Illumina Arrays , 2014, Genetic epidemiology.
[16] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[17] Jun Ho Yun,et al. Identification of differentially-expressed genes by DNA methylation in cervical cancer , 2015, Oncology letters.
[18] Shuigeng Zhou,et al. NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals , 2016, Nucleic acids research.
[19] Yair Lotan,et al. Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[20] Ru-Fang Yeh,et al. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. , 2009, Carcinogenesis.
[21] Hongzhe Li,et al. VARIABLE SELECTION AND REGRESSION ANALYSIS FOR GRAPH-STRUCTURED COVARIATES WITH AN APPLICATION TO GENOMICS. , 2010, The annals of applied statistics.
[22] Andrew E. Teschendorff,et al. Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions , 2012, Bioinform..
[23] Chunlong Zhang,et al. The Identification of Specific Methylation Patterns across Different Cancers , 2015, PloS one.
[24] Elisabeth Brambilla,et al. PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion. , 2015, Cancer research.
[25] N. Meinshausen,et al. Stability selection , 2008, 0809.2932.
[26] Andrew E. Teschendorff,et al. A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform , 2012, BMC Bioinformatics.
[27] T. Rikiyama,et al. GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation. , 2012, Cancer letters.
[28] Yan Li,et al. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma. , 2011, Cancer research.
[29] Hokeun Sun,et al. Network-based regularization for matched case-control analysis of high-dimensional DNA methylation data. , 2013, Statistics in medicine.
[30] Ehsan Motamedian,et al. Investigation on metabolism of cisplatin resistant ovarian cancer using a genome scale metabolic model and microarray data , 2015, Iranian journal of basic medical sciences.
[31] Luonan Chen,et al. The Dynamics of DNA Methylation Covariation Patterns in Carcinogenesis , 2014, PLoS Comput. Biol..
[32] P. Nederlof,et al. Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumors , 2011, Genes, chromosomes & cancer.
[33] J. Inazawa,et al. Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance , 2004, Cancer Research.
[34] F. Jasmine,et al. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips , 2013, Epigenetics.
[35] Yusuke Nakamura,et al. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. , 2010, Human molecular genetics.
[36] Chindo Hicks,et al. An Integrative Genomics Approach to Biomarker Discovery in Breast Cancer , 2011, Cancer informatics.
[37] Tso-Jung Yen,et al. Discussion on "Stability Selection" by Meinshausen and Buhlmann , 2010 .
[38] Ziwei Wang,et al. VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer , 2015, Medical Oncology.
[39] Y. Qin. Inferences for case-control and semiparametric two-sample density ratio models , 1998 .
[40] Trevor Hastie,et al. Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent. , 2011, Journal of statistical software.
[41] Mihaela Campan,et al. Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer , 2008, Molecular Cancer.
[42] M Taniwaki,et al. Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma , 2009, Oncogene.
[43] Shuang Wang,et al. Penalized logistic regression for high-dimensional DNA methylation data with case-control studies , 2012, Bioinform..
[44] Yan Li,et al. RBMS3 at 3p24 Inhibits Nasopharyngeal Carcinoma Development via Inhibiting Cell Proliferation, Angiogenesis, and Inducing Apoptosis , 2012, PloS one.
[45] Xifeng Dong,et al. Advances in tumor markers of ovarian cancer for early diagnosis. , 2014, Indian journal of cancer.
[46] H. Ashktorab,et al. DNA Methylation and Colorectal Cancer , 2014, Current Colorectal Cancer Reports.
[47] Jared C Roach,et al. Application of affymetrix array and massively parallel signature sequencing for identification of genes involved in prostate cancer progression , 2005, BMC Cancer.
[48] A. Feinberg,et al. Increased methylation variation in epigenetic domains across cancer types , 2011, Nature Genetics.
[49] Ruth Pidsley,et al. A data-driven approach to preprocessing Illumina 450K methylation array data , 2013, BMC Genomics.
[50] Piotr Zawierucha,et al. Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[51] H. Ji,et al. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex , 2014, Cell Research.
[52] S. Sze,et al. Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome , 2011, Cellular and Molecular Life Sciences.
[53] A. Kallioniemi,et al. High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer , 2007, British Journal of Cancer.
[54] Y. Qi,et al. Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer , 2014, Journal of the National Cancer Institute.
[55] Andrew E. Teschendorff,et al. An integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathways , 2013, Scientific Reports.
[56] P. V. van Diest,et al. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer , 2011, The Journal of pathology.
[57] B. Davidson,et al. Low Frequency of ESRRA–C11orf20 Fusion Gene in Ovarian Carcinomas , 2014, PLoS biology.
[58] M. Zhang,et al. DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes , 2015, PloS one.
[59] Zhen-Yu You,et al. Analyzing the differentially expressed genes and pathway cross‐talk in aggressive breast cancer , 2015, The journal of obstetrics and gynaecology research.
[60] Rui Feng,et al. NETWORK-REGULARIZED HIGH-DIMENSIONAL COX REGRESSION FOR ANALYSIS OF GENOMIC DATA. , 2014, Statistica Sinica.
[61] Andrew E. Teschendorff,et al. A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control , 2014, Bioinform..